SuperworthGoodRx shares outstanding GDRX
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 348.1M
- On a year earlier
- −2.5%
- fewer shares
GoodRx had 348.1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2.5% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 343.8M | −11% |
| FY2024 | 388.3M | −4% |
| FY2023 | 403.2M | −2% |
| FY2022 | 411.7M | −1% |
| FY2021 | 414.1M | +4% |
| FY2020 | 396.7M | +70% |
| FY2019 | 233.1M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 348.1M | −3% | |
| Q1 FY26 | 341.4M | −10% | |
| Q4 FY25 | 343.8M | −11% | |
| Q3 FY25 | 347.8M | −10% | |
| Q2 FY25 | 357.2M | −7% | |
| Q1 FY25 | 379.7M | −3% | |
| Q4 FY24 | 388.3M | −4% | |
| Q3 FY24 | 388.5M | −6% | |
| Q2 FY24 | 384.7M | −7% | |
| Q1 FY24 | 390M | −5% | |
| Q4 FY23 | 403.2M | −2% | |
| Q3 FY23 | 413.4M | +0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on GoodRx
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.